Global Hematology Analyzers and Reagents Market to Generate Revenue Of USD 19.5B by 2028

The global hematology analyzers and reagents market was worth around USD 8.1 billion in 2021 and is estimated to grow to about USD 19.5 billion by 2028, with a compound annual growth rate (CAGR) of approximately 7.1 percent over the forecast period

Hematology is the branch of medicine that deals with the study of blood and blood-related disorders. It involves understanding the causes, forecasting, treatment, or prevention of blood-related diseases. Hematology analyzers are machines used to run blood sample tests and assist in the counting of white blood cells, complete blood cells, coagulation tests, and reticulocyte analysis. Hematology reagents are chemicals used to perform morphological analysis of blood and its components.

The global hematology analyzers and reagents market is a growing lucrative market because they deliver extremely accurate test results at high speeds.

Covid-19 had a positive impact on the global market owing to the number of hospitalized critical patients. The unpredictability and evolving nature of the virus compelled medical facilities to run blood tests on every patient, Covid-19 or non-Covid-19 related, to provide result-yielding and correct medication.

There is a significant surge in the number of medical cases related to blood disorders. Some of the most common blood disorders are anemia, blood clots, hemophilia, or blood cancers like lymphoma, myeloma, and leukemia. There is also a rising awareness amongst the general population about the benefits of regular blood donation. A lot of organizations conduct blood donation campaigns as CSR initiatives.

Many governments have run exhaustive blood donation drives and other initiatives like declaring 14th June as World blood donor day. These mass efforts are expected to propel the global hematology analyzers and reagents market growth during the forecast period. Recent launches of technologically advanced machines like the launch of the DxH 900 hematology analyzer by Beckman Coulter along with heavy R&D investments in the field of hematology will aid the global market growth in the coming years.

However high costs associated with the hematology analyzers may hinder the global market growth whereas advanced technology in the field of medical equipment may generate numerous opportunities for the global market expansion. But a challenging factor around the globe is the quality of the hematology analyzers. The major threats include incorrect findings, which might lead to therapy delays or improper treatment.

The global hematology analyzers and reagents market is classified into product type, application, end-user, and region. Based on the product type, the global market is split into reagents and instruments. The application segment consists of hemorrhagic conditions, blood cancers, anemias immune system-related conditions, infection-related conditions, and others. By end-user, the market is bifurcated into research institutes, hospitals & clinics, diagnostic laboratories, and others.

North America is expected to lead the global hematology analyzers and reagents market during the forecast period owing to an increased number of chronic diseases. As per reports submitted by the American Society of Hematology, 3M of the American population is expected to be diagnosed with anemia, along with other diseases like HIV, and blood cancer. The advanced healthcare infrastructure of the region along with the presence of multiple key market players and robust investments in research & development activities is anticipated to assist the regional market growth.

Europe, owing to high per capita income along with increasing awareness about clinical diseases and precautionary measures like regular blood check-ups undertaken by the general population will contribute significantly to the regional market expansion.

Asia Pacific will register a higher CAGR in the coming years because of the rising population and technological advancements in the medical field. The growing number of medical facilities is expected to assist the region in generating high revenue.

Africa and Latin America may register slow growth during the forecast period because of economic instability, poor healthcare infrastructure, and weak spending capacity amongst the consumer group.

The major players operating in the global hematology analyzers and reagents market include Abbott, Siemens, Nihon Kohden, Danaher Corporation, Sysmex Corporation, Roche, BioSystems, Bio-Rad Laboratories, HORIBA, and Boule Diagnostics among others.

Recent Developments

• In April 2022, Sysmex Europe, launched the XQ-320, a three-part differential automated hematology analyzer. The XQ-320 is a reliable instrument that requires little sample volume, bench space, or maintenance.

Browse the full “Hematology Analyzers And Reagents Market By Product Type (Instruments And Reagents), By Application (Hemorrhagic Conditions, Blood Cancers, Anemias Immune System-Related Conditions, Infection-Related Conditions, And Others) By End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/hematology-analyzers-and-reagents-market

Global hematology analyzers and reagents market is segmented as follows:

By Product Type

• Instruments
• Reagents

By Application

• Hemorrhagic Conditions
• Blood Cancers
• Anemias
• Immune System Related Conditions
• Infection Related Conditions
• Others

By End User

• Diagnostic laboratories
• Hospitals & Clinics
• Research institutes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com